James E. O'Neill
Keine laufenden Positionen mehr
Karriereverlauf von James E. O'Neill
Ehemalige bekannte Positionen von James E. O'Neill
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | 13.05.2005 |
| Finanzdirektor/CFO | - | 13.05.2005 | |
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | - | - |
| Corporate Officer/Principal | 01.01.2014 | - |
Ausbildung von James E. O'Neill
| Massachusetts College of Liberal Arts | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- James E. O'Neill
- Erfahrung
